The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: A preliminary survey of hemostatic markers

Stephanie B. Jones, Charles W. Whitten, George J. Despotis, Terri G. Monk

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Acute normovolemic hemodilution (ANH), in which blood for autologous use is collected immediately before the onset of surgical blood loss, is a recommended autologous blood procurement technique for blood conservation. Both crystalloid and colloid replacement fluids have been used to maintain normovolemia during ANH, but few data are available to justify the use of a particular replacement fluid. Therefore, we designed a prospective, randomized study to determine if the replacement fluid choice affects various coagulation variables and perioperative blood loss. Forty adult patients, ASA physical status 1-3, scheduled for ANH during radical prostatectomy were randomly assigned to one of four replacement fluid groups: (a) Ringer's lactate, (b) 5% albumin, (c) 6% dextran 70 (DEX), or (d) 6% hetastarch (HES). After the induction of a standardized general anesthetic, all patients underwent ANH to a final hemoglobin level of 9 g/dL. Complete blood count, prothrombin time, partial thromboplastin time, fibrinogen, factors V and VIII levels, bleeding time, and thromboelastography (TEG®) measurements were obtained at similar time points in the procedure. When compared with baseline, activated partial thromboplastin time decreased and factor VIII levels increased in the postanesthesia care unit in both the Ringer's lactate and 5% albumin groups. The DEX and HES groups demonstrated a decrease in TEG® maximum amplitude between preoperative and postanesthesia care unit measurements and TEG® a (angle) was decreased from baseline in the DEX group. The changes in factor VIII, activated partial thromboplastin time, and TEG® measurements indicate that HES and DEX may attenuate the hypercoagulability related to surgery.

Original languageEnglish (US)
Pages (from-to)363-368
Number of pages6
JournalAnesthesia and Analgesia
Volume96
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Thrombelastography
Hemodilution
Hydroxyethyl Starch Derivatives
Colloids
Hemostatics
Dextrans
Partial Thromboplastin Time
Factor VIII
Albumins
Surgical Blood Loss
Preoperative Care
General Anesthetics
Bleeding Time
Thrombophilia
Factor V
Blood Cell Count
Prothrombin Time
Prostatectomy
Fibrinogen
Hemoglobins

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution : A preliminary survey of hemostatic markers. / Jones, Stephanie B.; Whitten, Charles W.; Despotis, George J.; Monk, Terri G.

In: Anesthesia and Analgesia, Vol. 96, No. 2, 01.02.2003, p. 363-368.

Research output: Contribution to journalArticle

@article{e90614d8f9684d91883090c8c8a1b81b,
title = "The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: A preliminary survey of hemostatic markers",
abstract = "Acute normovolemic hemodilution (ANH), in which blood for autologous use is collected immediately before the onset of surgical blood loss, is a recommended autologous blood procurement technique for blood conservation. Both crystalloid and colloid replacement fluids have been used to maintain normovolemia during ANH, but few data are available to justify the use of a particular replacement fluid. Therefore, we designed a prospective, randomized study to determine if the replacement fluid choice affects various coagulation variables and perioperative blood loss. Forty adult patients, ASA physical status 1-3, scheduled for ANH during radical prostatectomy were randomly assigned to one of four replacement fluid groups: (a) Ringer's lactate, (b) 5{\%} albumin, (c) 6{\%} dextran 70 (DEX), or (d) 6{\%} hetastarch (HES). After the induction of a standardized general anesthetic, all patients underwent ANH to a final hemoglobin level of 9 g/dL. Complete blood count, prothrombin time, partial thromboplastin time, fibrinogen, factors V and VIII levels, bleeding time, and thromboelastography (TEG{\circledR}) measurements were obtained at similar time points in the procedure. When compared with baseline, activated partial thromboplastin time decreased and factor VIII levels increased in the postanesthesia care unit in both the Ringer's lactate and 5{\%} albumin groups. The DEX and HES groups demonstrated a decrease in TEG{\circledR} maximum amplitude between preoperative and postanesthesia care unit measurements and TEG{\circledR} a (angle) was decreased from baseline in the DEX group. The changes in factor VIII, activated partial thromboplastin time, and TEG{\circledR} measurements indicate that HES and DEX may attenuate the hypercoagulability related to surgery.",
author = "Jones, {Stephanie B.} and Whitten, {Charles W.} and Despotis, {George J.} and Monk, {Terri G.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1097/00000539-200302000-00012",
language = "English (US)",
volume = "96",
pages = "363--368",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution

T2 - A preliminary survey of hemostatic markers

AU - Jones, Stephanie B.

AU - Whitten, Charles W.

AU - Despotis, George J.

AU - Monk, Terri G.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Acute normovolemic hemodilution (ANH), in which blood for autologous use is collected immediately before the onset of surgical blood loss, is a recommended autologous blood procurement technique for blood conservation. Both crystalloid and colloid replacement fluids have been used to maintain normovolemia during ANH, but few data are available to justify the use of a particular replacement fluid. Therefore, we designed a prospective, randomized study to determine if the replacement fluid choice affects various coagulation variables and perioperative blood loss. Forty adult patients, ASA physical status 1-3, scheduled for ANH during radical prostatectomy were randomly assigned to one of four replacement fluid groups: (a) Ringer's lactate, (b) 5% albumin, (c) 6% dextran 70 (DEX), or (d) 6% hetastarch (HES). After the induction of a standardized general anesthetic, all patients underwent ANH to a final hemoglobin level of 9 g/dL. Complete blood count, prothrombin time, partial thromboplastin time, fibrinogen, factors V and VIII levels, bleeding time, and thromboelastography (TEG®) measurements were obtained at similar time points in the procedure. When compared with baseline, activated partial thromboplastin time decreased and factor VIII levels increased in the postanesthesia care unit in both the Ringer's lactate and 5% albumin groups. The DEX and HES groups demonstrated a decrease in TEG® maximum amplitude between preoperative and postanesthesia care unit measurements and TEG® a (angle) was decreased from baseline in the DEX group. The changes in factor VIII, activated partial thromboplastin time, and TEG® measurements indicate that HES and DEX may attenuate the hypercoagulability related to surgery.

AB - Acute normovolemic hemodilution (ANH), in which blood for autologous use is collected immediately before the onset of surgical blood loss, is a recommended autologous blood procurement technique for blood conservation. Both crystalloid and colloid replacement fluids have been used to maintain normovolemia during ANH, but few data are available to justify the use of a particular replacement fluid. Therefore, we designed a prospective, randomized study to determine if the replacement fluid choice affects various coagulation variables and perioperative blood loss. Forty adult patients, ASA physical status 1-3, scheduled for ANH during radical prostatectomy were randomly assigned to one of four replacement fluid groups: (a) Ringer's lactate, (b) 5% albumin, (c) 6% dextran 70 (DEX), or (d) 6% hetastarch (HES). After the induction of a standardized general anesthetic, all patients underwent ANH to a final hemoglobin level of 9 g/dL. Complete blood count, prothrombin time, partial thromboplastin time, fibrinogen, factors V and VIII levels, bleeding time, and thromboelastography (TEG®) measurements were obtained at similar time points in the procedure. When compared with baseline, activated partial thromboplastin time decreased and factor VIII levels increased in the postanesthesia care unit in both the Ringer's lactate and 5% albumin groups. The DEX and HES groups demonstrated a decrease in TEG® maximum amplitude between preoperative and postanesthesia care unit measurements and TEG® a (angle) was decreased from baseline in the DEX group. The changes in factor VIII, activated partial thromboplastin time, and TEG® measurements indicate that HES and DEX may attenuate the hypercoagulability related to surgery.

UR - http://www.scopus.com/inward/record.url?scp=0037302941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037302941&partnerID=8YFLogxK

U2 - 10.1097/00000539-200302000-00012

DO - 10.1097/00000539-200302000-00012

M3 - Article

C2 - 12538178

AN - SCOPUS:0037302941

VL - 96

SP - 363

EP - 368

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -